Search results
Why Seattle Genetics, Alkermes Are Currently Outperforming Their Peers
Investor's Business Daily· 1 year agoBiotechs Seattle Genetics and Alkermes handily beat Wall Street's fourth-quarter estimates Thursday,...
Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 5 months agoIt has been about a month since the last earnings report for Seattle Genetics (SGEN). Shares have...
Why Is Axsome (AXSM) Down 30.3% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Axsome Therapeutics (AXSM). Shares have lost...
Axsome (AXSM) Down 9.8% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Axsome Therapeutics (AXSM). Shares have lost...
Biohaven Ltd. (BHVN) Surges 7.6%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 2 years agoBiohaven Ltd. (BHVN) witnessed a jump in share price last session on above-average trading volume....
Merck's Rumored $40 Billion Seagen Takeover Hits A Snag On Price
Investor's Business Daily· 2 years agoMerck's rumored takeover of cancer-focused biotech Seagen has stalled on price, according to a...
ADC startup ProfoundBio, led by Seagen veterans, raises $112M
BioPharma Dive via Yahoo Finance· 3 months agoThe Series B round will fund development of antibody-drug conjugates now in clinical testing, among...
Seagen CEO Clay Siegall Placed On Leave After Domestic Violence Claim
Investor's Business Daily· 2 years agoSeagen Chief Executive Clay Siegall was placed on leave after a domestic abuse allegation, the...
Regeneron to acquire 2seventy’s cell therapy pipeline
BioPharma Dive via Yahoo Finance· 3 months agoAbout 150 of the smaller company's employees will also transition to Regeneron, which is setting up...
Pfizer buys Seagen for $43B, boosts access to cancer drugs
Associated Press via Yahoo News· 1 year agoPfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor...